NCT03598595 2026-02-04Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory OsteosarcomaM.D. Anderson Cancer CenterPhase 1/2 Active not recruiting31 enrolled